Author: Asif Shajahan; Nitin T. Supekar; Anne S. Gleinich; Parastoo Azadi
Title: Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 Document date: 2020_4_3
ID: f0xsisdg_8
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.01.020966 doi: bioRxiv preprint observed O-glycosylation at two sites on the RBD of spike protein subunit S1, and this is the first report on the evidence for such glycan modification at a crucial viral attachment location. Sitespecific analysis of N-and O-glycosylation information of SARS-CoV-2 spike protein provides basic understanding .....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.01.020966 doi: bioRxiv preprint observed O-glycosylation at two sites on the RBD of spike protein subunit S1, and this is the first report on the evidence for such glycan modification at a crucial viral attachment location. Sitespecific analysis of N-and O-glycosylation information of SARS-CoV-2 spike protein provides basic understanding of the viral structure, crucial for the identification of immunogens for vaccine design. This in turn has the potential of leading to future therapeutic intervention or prevention of COVID-19.
Search related documents:
Co phrase search for related documents- basic understanding and vaccine design: 1
- future therapeutic intervention and therapeutic intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9
- glycan modification and vaccine design: 1
- SARS spike protein and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- SARS spike protein and therapeutic intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- SARS spike protein and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- spike protein and therapeutic intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- spike protein and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- spike protein and vaccine design immunogen: 1
- therapeutic intervention and vaccine design: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date